Bicycle Therapeutics PLC banner

Bicycle Therapeutics PLC
F:50BA

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
F:50BA
Watchlist
Price: 3.1 EUR -2.52% Market Closed
Market Cap: €213.1m

Wall St Price Targets

50BA Price Forecast
Based on 9 analysts

+225% Upside
from €3.1 today

Bicycle Therapeutics PLC (50BA)’s 12-month stock price forecast through October 2027 has a consensus target of €10.07, implying 225% upside. The forecast is based on price targets from 9 Wall Street analysts.

50BA Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 50BA yet.

Bicycle Therapeutics PLC Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 50BA's stock price target?
Price Target
10.07 EUR

According to Wall Street analysts, the average 1-year price target for 50BA is 10.07 EUR with a low forecast of 4.53 EUR and a high forecast of 13.19 EUR.

What is the Revenue forecast for Bicycle Therapeutics PLC?
Projected CAGR
30%

Over the last 8 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 8 years is 30%.

Back to Top